Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

QBRELIS 1 MG/ML SOLUTION

lisinopril
$4.4751per ML
High Outlier

Strength

1 mg/mL

Manufacturer

Azurity Pharmaceuticals Inc.

NDC

52652300101

Classification

Brand

Dosage Form

SOLUTION

Route

ORAL

Last Updated

1/1/2026

Active Ingredients

LISINOPRIL

Approval Type

New Drug (NDA)

FDA Application

NDA208401

On Market Since

8/29/2016

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+2.9%

1Y

+2.9%

3Y

+19.1%

5Y

N/A

All

+30.7%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

EPANED 1 MG/ML ORAL SOLUTION
Brand
52652400101•Azurity Pharmaceuticals Inc.
$4.4523
per ML
LOTREL 10-20 MG CAPSULE
Brand
00078036405•Novartis Pharmaceuticals Corporation
$11.2952
per EA
LOTREL 5-10 MG CAPSULE
Brand
00078040505•Novartis Pharmaceuticals Corporation
$11.5553
per EA
LOTREL 5-20 MG CAPSULE
Brand
00078040605•Novartis Pharmaceuticals Corporation
$12.2080
per EA
ZESTRIL 10 MG TABLET
Brand
24979024007•Upsher-Smith Laboratories LLC
$12.5244
per EA
VASOTEC 5 MG TABLET
Brand
00187014130•Bausch Health US LLC
$15.4858
per EA
VASOTEC 5 MG TABLET
Brand
00187014190•Bausch Health US LLC
$15.4858
per EA
LOTREL 10-40 MG CAPSULE
Brand
00078037905•Novartis Pharmaceuticals Corporation
$15.6209
per EA
VASOTEC 10 MG TABLET
Brand
00187014210•Bausch Health US LLC
$16.9507
per EA
VASOTEC 10 MG TABLET
Brand
00187014230•Bausch Health US LLC
$16.9507
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy